The supportive role of HDAC4 in cancer cell metabolic reprogramming, inhibition of HDAC4 sensitizing lung cancer to chemotherapy and radiotherapy 33, 34, all these phenomena support further investigation of HDAC4 as a potential therapeutic target. This evidence concerns the gene HDAC4 and cancer.